![Frederick Pierce](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick Pierce
No open positions remaining
Net worth: 143 209 $ as of 31/07/2026
Profile
Frederick E.
Pierce was the founder of Decoy Therapeutics, Inc. (Old), founded in 2020, holding the title of Chief Executive Officer & Director.
Mr. Pierce is the founder of Decoy Therapeutics, Inc., founded in 2025, holding the title of Chief Executive Officer & Director.
Mr. Pierce is also the founder of FEP Capital Advisors LLC..
Mr. Pierce is currently Director at Canadian Entrepreneurs In New England.
Former positions include Interim Chief Executive Officer at Glycogenesys, Inc. from 1998 to 2006; Chairman & Chief Executive Officer at Microbial Machines, Inc.; Chairman, President & Chief Executive Officer at Innovation1 Biotech, Inc. from 2022 to 2024; Chief Executive Officer & Director at Salarius Pharmaceuticals, Inc.; Chairman at Leadership Counsel for Justice & Accountability from 2017 to 2020; President-US & International Operations at SemBioSys Genetics, Inc.; Vice President-Investor Relations at Javelin Pharmaceuticals, Inc.; and Vice President-Investor & Media Relations at MetaStat, Inc. Education includes undergraduate studies at Hampshire College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
5.32% | 31/08/2026 | 34,844 ( 5.32% ) | 143 209 $ | 31/07/2026 |
Frederick Pierce active positions
| Companies | Position | Start |
|---|---|---|
Canadian Entrepreneurs In New England
 Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Operates membership organization to support Canadian technology and life sciences entrepreneurs | Director/Board Member | - |
Former positions of Frederick Pierce
| Companies | Position | End |
|---|---|---|
| INNOVATION1 BIOTECH INC. | Chief Executive Officer | 07/11/2024 |
Leadership Counsel for Justice & Accountability
 Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Provides research, legal representation and policy advocacy services | Chairman | 01/01/2020 |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | President | 01/06/2006 |
| DECOY THERAPEUTICS INC. | Chief Executive Officer | - |
Decoy Therapeutics, Inc.
 Decoy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical biopharmaceutical company | Founder | - |
Training of Frederick Pierce
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Commercial Services |
SemBioSys Genetics, Inc.
 SemBioSys Genetics, Inc. BiotechnologyHealth Technology Develops protein-based pharmaceuticals and non-pharmaceutical products | Health Technology |
Hampshire College
 Hampshire College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
MetaStat, Inc.
 MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
FEP Capital Advisors LLC | |
Innovation1 Biotech, Inc.
 Innovation1 Biotech, Inc. Internet RetailRetail Trade Sells consumer cannabidiol products through online | Retail Trade |
Canadian Entrepreneurs In New England
Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Operates membership organization to support Canadian technology and life sciences entrepreneurs | Commercial Services |
Salarius Pharmaceuticals, Inc.
 Salarius Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on developing treatment for cancer | Health Technology |
SanaRx Biotherapeutics, Inc.
 SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan diseases drugs | Health Technology |
Leadership Counsel for Justice & Accountability
Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Provides research, legal representation and policy advocacy services | Commercial Services |
Decoy Therapeutics, Inc.
Decoy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Frederick Pierce
